AU2001244688A1 - Heterocycle derivatives and drugs - Google Patents

Heterocycle derivatives and drugs

Info

Publication number
AU2001244688A1
AU2001244688A1 AU2001244688A AU4468801A AU2001244688A1 AU 2001244688 A1 AU2001244688 A1 AU 2001244688A1 AU 2001244688 A AU2001244688 A AU 2001244688A AU 4468801 A AU4468801 A AU 4468801A AU 2001244688 A1 AU2001244688 A1 AU 2001244688A1
Authority
AU
Australia
Prior art keywords
alkyl
different
same
group
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001244688A
Other languages
English (en)
Inventor
Kazuya Mori
Masahiko Okano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of AU2001244688A1 publication Critical patent/AU2001244688A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2001244688A 2000-03-31 2001-03-30 Heterocycle derivatives and drugs Abandoned AU2001244688A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000098874 2000-03-31
JP2000-98874 2000-03-31
JP2000-336464 2000-11-02
JP2000336464 2000-11-02
PCT/JP2001/002822 WO2001072710A1 (en) 2000-03-31 2001-03-30 Heterocycle derivatives and drugs

Publications (1)

Publication Number Publication Date
AU2001244688A1 true AU2001244688A1 (en) 2001-10-08

Family

ID=26589216

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001244688A Abandoned AU2001244688A1 (en) 2000-03-31 2001-03-30 Heterocycle derivatives and drugs

Country Status (10)

Country Link
US (1) US6794389B2 (enExample)
EP (1) EP1306372B1 (enExample)
KR (1) KR20020083533A (enExample)
CN (1) CN1242993C (enExample)
AT (1) ATE449084T1 (enExample)
AU (1) AU2001244688A1 (enExample)
CA (1) CA2403605A1 (enExample)
DE (1) DE60140545D1 (enExample)
RU (1) RU2268260C2 (enExample)
WO (1) WO2001072710A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024666A2 (en) * 2000-09-20 2002-03-28 Merck Patent Gmbh 4-amino-quinazolines
ATE383860T1 (de) * 2000-11-02 2008-02-15 Nippon Shinyaku Co Ltd Chinazolinderivate und -arzneimittel
RU2003130752A (ru) * 2001-03-19 2005-03-10 Ниппон Синяку Ко., Лтд. (Jp) Противозудные средства
US6907295B2 (en) * 2001-08-31 2005-06-14 Biocontrol Medical Ltd. Electrode assembly for nerve control
US7829566B2 (en) * 2001-09-17 2010-11-09 Werner Mederski 4-amino-quinazolines
JP4513566B2 (ja) * 2002-04-26 2010-07-28 日本新薬株式会社 キナゾリン誘導体及び医薬
JP4805234B2 (ja) * 2002-12-16 2011-11-02 キッセイ薬品工業株式会社 経口固形医薬
WO2006074147A2 (en) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
JP5129957B2 (ja) 2003-07-03 2013-01-30 ミリアド ジェネティクス, インコーポレイテッド カスパーゼの活性化因子およびアポトーシスの誘発因子としての4−アリールアミノ−キナゾリン
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
US20050165032A1 (en) * 2004-01-23 2005-07-28 Norman Mark H. Vanilloid receptor ligands and their use in treatments
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
WO2007040231A1 (ja) 2005-10-03 2007-04-12 Nippon Shinyaku Co., Ltd. キナゾリン誘導体及び医薬
RU2314295C2 (ru) * 2006-03-01 2008-01-10 Федеральное Государственное Образовательное Учреждение Высшего Профессионального Образования "Южный Федеральный Университет" 2-гетарилзамещенные 1,3-трополона, способ их получения (варианты) и фармацевтическая композиция антимикробного действия
MX2009012117A (es) * 2007-05-09 2009-11-23 Pfizer Composiciones y derivados heterociclicos sustituidos y su uso farmaceutico como antibacterianos.
EP2017294A1 (de) 2007-07-16 2009-01-21 Sika Technology AG Hitzehärtender Schaum
BRPI0923786C8 (pt) 2008-12-30 2021-05-25 Arqule Inc compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos e composições farmacêuticas compreendendo ditos compostos
WO2012027495A1 (en) 2010-08-27 2012-03-01 University Of The Pacific Piperazinylpyrimidine analogues as protein kinase inhibitors
SG11201403744YA (en) 2011-12-28 2014-09-26 Fujifilm Corp Novel nicotinamide derivative or salt thereof
WO2024258849A2 (en) * 2023-06-13 2024-12-19 The Trustees Of Indiana University Small molecule antiviral drug treatment for human papillomavirus infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753981A (en) 1970-07-15 1973-08-21 Squibb & Sons Inc 4-amino-2-styrylquinazoline compounds
PT100905A (pt) 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
JP2657760B2 (ja) 1992-07-15 1997-09-24 小野薬品工業株式会社 4−アミノキナゾリン誘導体およびそれを含有する医薬品
WO1997020821A1 (en) * 1995-12-01 1997-06-12 Novartis Ag Heteroaryl derivatives
EP0973513A4 (en) 1996-10-23 2003-03-19 Zymogenetics Inc COMPILATIONS AND METHOD FOR TREATING BONE DEFICIENCY
CA2226058C (en) 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives
AR012634A1 (es) 1997-05-02 2000-11-08 Sugen Inc Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
DE69826278T2 (de) 1997-05-30 2005-11-10 Banyu Pharmaceutical Co., Ltd. 2-oxoimidazol-derivate
AU8748798A (en) 1997-08-22 1999-03-16 Kyowa Hakko Kogyo Co. Ltd. 4-aminoquinazoline derivatives
RU2202344C2 (ru) * 1998-03-26 2003-04-20 Джапан Тобакко Инк. Антагонисты ноцицептина, производные амида, аналгетик, способ инициирования антагонистического действия к ноцицептину, способ лечения боли, фармацевтические композиции
RU2003130752A (ru) 2001-03-19 2005-03-10 Ниппон Синяку Ко., Лтд. (Jp) Противозудные средства

Also Published As

Publication number Publication date
CN1242993C (zh) 2006-02-22
KR20020083533A (ko) 2002-11-02
RU2002129100A (ru) 2004-02-27
CA2403605A1 (en) 2002-09-18
US6794389B2 (en) 2004-09-21
ATE449084T1 (de) 2009-12-15
RU2268260C2 (ru) 2006-01-20
CN1422255A (zh) 2003-06-04
EP1306372A1 (en) 2003-05-02
US20030119855A1 (en) 2003-06-26
WO2001072710A1 (en) 2001-10-04
EP1306372B1 (en) 2009-11-18
EP1306372A4 (en) 2004-03-17
DE60140545D1 (enExample) 2009-12-31

Similar Documents

Publication Publication Date Title
AU2001244688A1 (en) Heterocycle derivatives and drugs
DK1357111T3 (da) 2-pyridonderivater med affinitet for cannabinoid type 2-receptor
ATE208776T1 (de) Pyrazolo(1,5-a) pyrimidin-derivate
EP1176959A4 (en) NEW PROLIN COMPOUNDS AS A MICROBICIDE AGENT
AU8345491A (en) Heterocyclic derivatives
GB8612218D0 (en) Site specific alkylating agents
IL167958A (en) 2-thio 3-hydroxypyridine derivatives
DK0784054T3 (da) 1,2,3,4-tetrahydroquinoxalinderivater og deres anvendelse som glutamatreceptorantagonister
FI944822A0 (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
WO2001062705A8 (en) Aminoalcohol derivatives
KR930700485A (ko) 피리미딘 뉴클레오시드 유도체
DE60132484D1 (de) Chinazolinderivate und -arzneimittel
WO2005046672A3 (fr) Utilisation d’inhibiteurs de glucosidase pour une therapie de la mucoviscidose
DK0618193T3 (da) Nitrogenholdige, bicycliske derivater som prolyl-endopeptidaseinhibitorer
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
KR950702194A (ko) 티아졸린 유도체
EP0882721A4 (en) SIALIC ACIDS 2,7-DIDEOXY-7-FLUORO- 2, 3-DIDEHYDRO A QUADRUPLE SUBSTITUTION
TR200003652T2 (tr) Glisin antagonistleri olarak tetrahidrokuinolin türevleri.
ATE134376T1 (de) Mono- und bis-alkylaminoanthracycline
DE69529807D1 (de) Neue Parabansäure-Derivate als Aldose-Reduktase Inhibitoren
AU2001228862A1 (en) Remedies or preventives for liver diseases containing diaminotrifluoromethylpyridine derivatives
DK233788A (da) Herbicid
BR0010811A (pt) Derivados de tetrazolinona